Liquidia Technologies, Inc.
Clinical trials sponsored by Liquidia Technologies, Inc., explained in plain language.
-
New inhaler tested for deadly lung pressure disease
Disease control OngoingThis study is testing the safety and side effects of a new dry powder inhaler version of a medication called treprostinil. It involves about 80 adults with pulmonary hypertension, a serious condition of high blood pressure in the lungs, often linked to lung scarring. The main goa…
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New inhaled treatment tested for serious lung pressure disease
Disease control OngoingThis study is testing the safety and side effects of an inhaled medication called L606 for adults with pulmonary hypertension, a serious condition where blood pressure is too high in the lungs. The trial follows 28 patients for up to a year to see how well they tolerate switching…
Phase: PHASE3 • Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC